Makers Laboratories Limited (BOM:506919)
India · Delayed Price · Currency is INR 151.70
+2.00 (1.34%)
At close: Jul 27, 2026
Makers Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 1,406 | 1,208 | 1,044 | 1,013 | 1,272 |
Other Revenue | 2.78 | 3.75 | - | - | 9.65 |
| 1,409 | 1,211 | 1,044 | 1,013 | 1,282 | |
Revenue Growth | 16.30% | 16.03% | 3.07% | -20.98% | 86.72% |
Cost of Revenue | 683.95 | 565.67 | 561.9 | 422.82 | 537.25 |
Gross Profit | 724.78 | 645.59 | 481.99 | 589.96 | 744.41 |
Selling, General & Admin | 167.91 | 148.61 | 144.02 | 120.76 | 127.85 |
Other Operating Expenses | 407.19 | 409.34 | 322.82 | 432.16 | 415.5 |
Operating Expenses | 620.38 | 605.81 | 512.28 | 595.34 | 583.59 |
Operating Income | 104.4 | 39.78 | -30.29 | -5.38 | 160.82 |
Interest Expense | -6.48 | -10.83 | -17.56 | -19.02 | -14.39 |
Interest & Investment Income | 0.08 | 0.05 | 5.92 | 8.79 | 7.5 |
Currency Exchange Gain (Loss) | 11.69 | 3.86 | 3.84 | 7.04 | 4.31 |
Other Non Operating Income (Expenses) | -1.16 | -1.94 | -1.53 | 0.13 | -0.05 |
EBT Excluding Unusual Items | 108.53 | 30.92 | -39.61 | -8.43 | 158.2 |
Gain (Loss) on Sale of Investments | 2.4 | 2.72 | 0.1 | 0.01 | 0.74 |
Gain (Loss) on Sale of Assets | 0.57 | 102.89 | 0.56 | 0.18 | -0.52 |
Asset Writedown | - | 5.49 | -0.23 | -0.14 | -1.61 |
Other Unusual Items | - | -7.91 | - | - | 0.08 |
Pretax Income | 111.49 | 134.11 | -39.17 | -8.39 | 156.88 |
Income Tax Expense | 32.89 | 25.03 | 8.94 | 13.53 | 39.71 |
Earnings From Continuing Operations | 78.61 | 109.08 | -48.11 | -21.92 | 117.17 |
Minority Interest in Earnings | -55.1 | -34.17 | -14.54 | -25.59 | -67.39 |
Net Income | 23.51 | 74.91 | -62.64 | -47.51 | 49.78 |
Net Income to Common | 23.51 | 74.91 | -62.64 | -47.51 | 49.78 |
Net Income Growth | -68.61% | - | - | - | - |
Shares Outstanding (Basic) | 6 | 6 | 6 | 6 | 5 |
Shares Outstanding (Diluted) | 6 | 6 | 6 | 6 | 5 |
Shares Change | - | - | -1.89% | 22.31% | - |
EPS (Basic) | 3.98 | 12.70 | -10.62 | -7.90 | 10.12 |
EPS (Diluted) | 3.98 | 12.70 | -10.62 | -7.90 | 10.12 |
EPS Growth | -68.61% | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 105.79 | -80.2 | -57.82 | -215.27 | 86.1 |
Free Cash Flow Per Share | 17.93 | -13.59 | -9.80 | -35.80 | 17.51 |
Gross Margin | 51.45% | 53.30% | 46.17% | 58.25% | 58.08% |
Operating Margin | 7.41% | 3.28% | -2.90% | -0.53% | 12.55% |
Profit Margin | 1.67% | 6.18% | -6.00% | -4.69% | 3.88% |
Free Cash Flow Margin | 7.51% | -6.62% | -5.54% | -21.25% | 6.72% |
EBITDA | 144.81 | 83.03 | 11.62 | 33.69 | 198.23 |
EBITDA Margin | 10.28% | 6.86% | 1.11% | 3.33% | 15.47% |
D&A For EBITDA | 40.41 | 43.25 | 41.91 | 39.07 | 37.41 |
EBIT | 104.4 | 39.78 | -30.29 | -5.38 | 160.82 |
EBIT Margin | 7.41% | 3.28% | -2.90% | -0.53% | 12.55% |
Effective Tax Rate | 29.49% | 18.67% | - | - | 25.31% |
Revenue as Reported | 1,423 | 1,326 | 1,059 | 1,036 | 1,298 |